DAWNRAYS Pharmaceutical (02348.HK) announced that its subsidiary, Suzhou Dawnrays Pharmaceutical Co., Ltd., has recently received pharmaceutical registration approval from the State Food and Drug Administration (SFDA) for the drug Potassium Citrate Extended-release Tablets - Jie Shi Tong - 1.08g and 0.54g used for the treatment of urinary stones, and the approval numbers are Guo Yao Zhun Zi H20110139 and Guo Yao Zhun Zi H20110140 respectively.

The board believes that Jie Shi Tong will further enhance the group's product portfolio and bring new business opportunity to the group.